How long does it take to continue taking Bestifan (Viliru) and the guidance on the course of treatment?

Belzutifan (Belzutifan) is an oral HIF-2α inhibitor, mainly used to treat renal cell carcinoma and related tumors related to VHL (von Hippel-Lindau disease). The drug blocks tumor cell proliferation signals by inhibiting the activity of hypoxia-inducible factor HIF-2α, thereby inhibiting tumor growth and angiogenesis. In clinical practice, the goal of besotivan is to control the disease in the long term and delay tumor progression, rather than to cure it immediately.

Regarding the course of treatment, current clinical studies and guidelines recommend continued oral administration until disease progression or intolerable adverse reactions occur. The standard dosage is 80 mg once daily (the specific dosage needs to be adjusted according to the doctor's assessment of individual conditions). Since the drug is a targeted therapy, the length of the treatment course is usually based on the patient's tumor burden, tolerance and imaging examination results, rather than a fixed number of days or months. Patients should regularly review imaging, blood indicators, and liver and kidney function under the guidance of a doctor to evaluate efficacy and safety.

In terms of medication management, patients need to pay attention to taking medications regularly and avoid missing doses. During long-term medication, if mild to moderate adverse reactions occur, such as fatigue, anemia or mild blood index abnormalities, treatment can be continued and symptomatic treatment can be carried out under the guidance of a doctor. For serious adverse reactions, such as significant hematological abnormalities or liver function abnormalities, it may be necessary to temporarily discontinue the drug or adjust the dose, and then continue treatment after recovery. Proper monitoring and individualized adjustments are the keys to ensuring efficacy and safety.

Generally speaking, there is no fixed end time for the treatment course of bestifan. The principle of its use is to continue taking it until tumor progression or intolerable side effects occur. Patients should maintain close communication with their attending doctors throughout the entire treatment process, conduct regular follow-up visits and monitor indicators, and reasonably adjust their medication regimen. At the same time, lifestyle and nutritional support are also parts that cannot be ignored in long-term treatment, which can help improve tolerance and ensure the sustainability of the effect.

Reference materials:https://www.drugs.com/